haematological malignancy
Item
an underlying haematological malignancy including acute myeloid leukaemia in cr1 but with poor prognostic features or in >cr1 or in relapse; acute lymphoblastic leukaemia; transformed myelodysplasia, chronic myeloid leukaemia (accelerated phase or blast transformation, poor response or intolerance of tyrosine kinase inhibitors), myeloma. patients may be in remission, partial remission or relapse.
boolean
C0376545 (UMLS CUI [1])
chemotherapy
Item
no concurrent or recent (within 3 weeks) chemotherapy for the underlying haematological condition
boolean
C0392920 (UMLS CUI [1])
patients with relapsed leukaemia, bm blasts must represent < 20 percent of bm nucleated cells.
Item
for patients with relapsed leukaemia, bm blasts must represent < 20 percent of bm nucleated cells.
boolean
C1982687 (UMLS CUI [1])
C0920028 (UMLS CUI [2])
although the bm remission status is not important, patients must have cellularity > 10 percent
Item
although the bm remission status is not important, patients must have cellularity > 10 percent.
boolean
C1561532 (UMLS CUI [1])
as malignant plasma cells may or may not express cd66 antigens, patients with myeloma must have less than 30 percent plasma cells (as a percentage of total nucleated cells) in the bm at the time of the study
Item
as malignant plasma cells may or may not express cd66 antigens, patients with myeloma must have less than 30 percent plasma cells (as a percentage of total nucleated cells) in the bm at the time of the study.
boolean
C0848076 (UMLS CUI [1])
C0108797 (UMLS CUI [2])
C1319846 (UMLS CUI [3])
age
Item
age = or >18 yrs.
boolean
C0001779 (UMLS CUI [1])
who performance status
Item
who performance status of 0, 1 or 2 (appendix 5).
boolean
C1298650 (UMLS CUI [1])
life expectancy
Item
predicted life-expectancy of greater than four months.
boolean
C0023671 (UMLS CUI [1])
human anti-mouse antibodies
Item
patients must be negative for human anti-mouse antibodies (hama).
boolean
C1291910 (UMLS CUI [1])
peripheral blood counts
Item
wbc < 30 x 109/l (absolute neutrophil count >0.5 x 109/l) platelets > 50 x 109/l (platelet support is permitted)
boolean
C0005771 (UMLS CUI [1])
biochemical indices
Item
plasma creatinine < 120 micromol/l (or creatinine clearance or edta clearance > 50 ml/min) plasma bilirubin < 30 micromol/l ast no more than 2.5 x upper limit of the normal range.
boolean
C1278055 (UMLS CUI [1])
C1278036 (UMLS CUI [2])
informed consent
Item
patient must be able to provide written informed consent.
boolean
C0021430 (UMLS CUI [1])
comorbidity
Item
any serious intercurrent disease.
boolean
C0009488 (UMLS CUI [1])
patients with bm cellularity < 10%
Item
patients with bm cellularity < 10%.
boolean
C1561532 (UMLS CUI [1])
history of atopic asthma, eczema or allergy to rodent protein, confirmed history of severe allergic reactions to penicillin or streptomycin
Item
history of atopic asthma, eczema or allergy to rodent protein, confirmed history of severe allergic reactions to penicillin or streptomycin.
boolean
C0020517 (UMLS CUI [1])
C0038425 (UMLS CUI [2])
C0030842 (UMLS CUI [3])
positive hama
Item
positive hama.
boolean
C1291910 (UMLS CUI [1])
patients unable to provide informed consent or who are unable to co-operate for reasons of poor mental or physical health
Item
patients unable to provide informed consent or who are unable to co-operate for reasons of poor mental or physical health.
boolean
C0021430 (UMLS CUI [1])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])
pregnancy
Item
pregnancy
boolean
C0549206 (UMLS CUI [1])